● Recruiting

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

Condition: Cholangiocarcinoma · Sponsor: National Cancer Institute, Naples

PhasePhase 2

Planned participants38

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Neoadjuvant chemo- and immunotherapy ameliorate the recurrence rate of cholangiocarcinoma (CCA) at 12 months after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Alessandro Ottaiano · 08117770344 · a.ottaiano@istitutotumori.na.it

Always discuss trial participation with your own doctor first.

Locations (6)

Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale	Naples, Italia, Italy	Recruiting
Ospedale Cardarelli, Napoli	Naples, Italia, Italy	Not Yet Recruiting
Università di Napoli "Federico II", Napoli	Naples, Italia, Italy	Not Yet Recruiting
Ospedale san Camillo Forlanini/Spallanzani, Roma	Roma, Italia, Italy	Not Yet Recruiting
Ospedale Mauriziano, Umberto I°	Torino, Italia, Italy	Not Yet Recruiting
Università di Verona, Ospedale Borgoroma, Verona	Verona, Italia, Italy	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06341764